No Detail Found!

Efficacy of mifepristone plus Shenqi Yangxue Granulesfor hysteromyoma complicated with anemia and its effect on hemoglobin, erythrocytes and hematocrit

Author(s)
Renli Ye Department of Obstetrics and Gynecology, Tianchang Hospital of traditional Chinese Medicine,Tianchang City, Anhui Province,China
Yan Jiang Department of Obstetrics and Gynecology, Tianchang Hospital of traditional Chinese Medicine,Tianchang City, Anhui Province,China
Abstract
To assess the clinical efficacy of mifepristone complicated with anemia and its effect on the hemoglobin, red blood cell, as well as hematocrit. Sixty patients with hysteromyoma complicated with anemia between December 2018 and December 2020 were recruited and assigned to receive either mifepristone (control group, n=30) or mifepristone plus Shenqi Yangxue Granules (experimental group, n=30) based on the admission order. The two groups were compared in clinical efficiency, incidence of adverse reactions, myoma volume, uterine volume, and clinical indicators. The experimental group got a notably higher total treatment efficiency than the control group (P<0.05). The experimental group obtained a remarkably lower incidence of adverse reactions and smaller myoma volume and uterine volume than the control group (P<0.05). Patients in the experimental group showed lower hemoglobin levels and higher hematocrit levels than the control group (P<0.05). Combined therapy of mifepristone plus Shenqi Yangxue Granules resulted in lower erythrocyte aggregation index, erythrocyte sedimentation rate, in patients in the study group than those receiving mifepristone alone in the control group (P<0.05). Mifepristone plus Shenqi Yangxue Granules for patients with hysteromyoma complicated with anemia mitigates the clinical symptoms of patients and reduces the incidence of adverse reactions, with a high safety profile.
Publication Details
Page(s) 905-910
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 35, Issue: S3, Year: 2022

Request the full text from PASTIC

Keywords
hysteromyoma with anemia, blood picture, Shenqi Yangxue Granules, Mifepristone
References
Allanson ER,Copson S,Spilsbury K,Criddle S,Jennings B,Doherty DA,Dickinson JE .2021 .Pretreatment with mifepristone compared with misoprostol alone for delivery after fetal death between 14 and 28 weeks of gestation: A randomized controlled trial. Obstet Gynecol, 137(5) : 801-809.
Check JH,Check D,Poretta T .2021 .Palliative Benefits of oral mifepristone for the treatment of metastatic fibroblastic osteosarcoma. Anticancer Res., 41(4) : 2111-2115.
Check JH,Check D,Srivastava MD,Poretta T,Aikins JK .2020 .Treatment with mifepristone allows a patient with end-stage pancreatic cancer in hospice on a morphine drip to restore a decent quality of life. Anticancer Res., 40(12) : 6997-7001.
Clements W,Ang WC,Law M,Goh GS M,Aust N Z. J. Obstet Gynaecol M .2020 .Treatment of symptomatic fibroid disease using uterine fibroid embolisation: An australian perspective. , 60(3) : 324-329.
D'Hoore T,Timmerman D,Laenen A,Maleux G .2020 .Long-term outcome and pre-interventional predictors for late intervention after uterine fibroid embolization. Eur. J. Obstet. Gynecol. Reprod. Biol, 247 : 149-155.
Ehrnsten L,Altman D,Ljungblad A,Kopp Kallner H A .2020 .Efficacy of mifepristone and misoprostol for medical treatment of missed miscarriage in clinical practice-A cohort study. Acta Obstet Gynecol Scand, 99(4) : 488-493.
El-Agwany AS .2018 .Huge broad ligament fibroid with paracervical extension: A safe approach by same setting myomectomy before hysterectomy. J. Med, 26(1) : 45-47.
Frijlingh M,De Milliano I,Hehenkamp WJK,Huirne JAF .2020 .Differences in fibroid vascularity after three months of pre-treatment with leuprolide acetate or ulipristal acetate: A pilot study. Eur. J. Obstet. Gynecol. Reprod. Biol, 245 : 186-192.
Frye LJ,Kilfedder C,Blum J,Winikoff B .2020 .A cross-sectional analysis of mifepristone, misoprostol, and combination mifepristone-misoprostol package inserts obtained in 20 countries. , 101(5) : 315-320.
Gubbi S,Muniyappa R,Sharma ST,Grewal S,McGlotten R,Nieman LK .2021 .Mifepristone Improves Adipose Tissue Insulin Sensitivity in Insulin Resistant Individuals. J Clin Endocrinol Metab, 106(5) : 1501-1515.
Guilbert E,Wagner MS,Munro S,Wilcox ES,Dunn S,Soon JA,Norman WV .2020 .Slow implementation of mifepristone medical termination of pregnancy in Quebec, Canada: A qualitative investigation. Eur. J. Contracept Reprod Health Care, 25(3) : 190-198.
Hcini N,Jolivet A,Pomar L,McHirgui A,Maamri F,Elcadhi Y,Carles G Y .2020 .Cervical maturation using mifepristone in women with normal pregnancies at or beyond term. Eur. J. Obstet Gynecol Reprod Biol, 248 : 58-62.
Kim HJ,Kim SH,Oh YS,Heo SH,Kim KH,Kim DY,Chae HD .2021 .Effects of phthalate esters on human myometrial and fibroid cells: Cell culture and NOD-SCID mouse data. Reprod Sci., 28(2) : 479-487.
Landis GN,Doherty DV,Yen CA,Wang L,Fan Y,Wang I,Tower J I .2021 .Metabolic signatures of life span regulated by mating, sex peptide and mifepristone/ RU486 in female Drosophila melanogaster. J. Gerontol A Biol. Sci. Med, 76(2) : 195-204.
Luo J,Qi Q,Chen Y,Wang Y,Xie Q Y .2021 .Effect of GnRH-antagonist, mifepristone and letrozole on preventing ovarian hyperstimulation syndrome in rat model. Reprod. Biomed. Online, 42(2) : 291-300.
Mollier J,Patel NR,Amoah A,Hamady M,Quinn SD M .2020 .Clinical, imaging and procedural risk factors for intrauterine infective complications after uterine fibroid embolisation: a retrospective case control study. Cardiovasc Intervent Radiol, 43(12) : 1910-1917.
Munro S,Guilbert E,Wagner MS,Wilcox ES,Devane C,Dunn S,Norman WV .2020 .Perspectives among canadian physicians on factors influencing implementation of mifepristone medical abortion: A national qualitative study. Ann Fam. Med, 18(5) : 413-421.
Osorio W,Posada N,Cano J,Tamayo S,Giraldo J .2021 .Hysteroscopic myomectomy for submucosal type 2 fibroids with cold enucleation technique and complete fibroid extraction using a double-lumen intracervical cannula. Fertil Steril, 115(2) : 522-524.
Ota K,Takahashi T,Kamo N,Endo Y,Furukawa S,Soeda S S .2020 .Successful management of a submucosal fibroid using a hysteroscopic morcellator system in a patient with a history of total proctocolectomy: A case report. J. Obstet. Gynaecol. Res., 46(11) : 2450-2453.
Rodriguez MI,Gulmezoglu AM .2020 .Mifepristone for emergency contraception case for recommendation in practice guidelines. Contraception, 102(6) : 383-384.
Sparic R,Papoutsis D,Bukumiric Z,Kadija S,Spremovic Radjenovic S,Malvasi A,Tinelli A .2020 .The incidence of and risk factors for complications when removing a single uterine fibroid during cesarean section: A retrospective study with use of two comparison groups. J. Matern Fetal Neonatal Med, 33(19) : 3258-3265.
Yan H,Zhang C,Liu T,Liu J .2020 .Mifepristone regulates the multidrug resistance via miR-758/MEPE of Hela cell lines. Eur. J. Gynaecol. Oncol, 41(3) : 214-220.
Yoneto K,Li SK,Higuchi WI,Jiskoot W,Herron JN .1996 .Fluorescence probe studies of the interactions of 1-alkyl-2-pyrrolidones with stratum corneum lipid liposomes. J. Pharm. Sci., 85(5) : 511-517.
0

Citations

0

Downloads

16

Views